Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
BMC Womens Health ; 22(1): 119, 2022 04 14.
Artigo em Inglês | MEDLINE | ID: mdl-35421983

RESUMO

BACKGROUND: Breast leiomyoma is a rare benign mesenchymal tumor, accounting for less than 1% of all breast neoplasms. Cases of breast atypical leiomyoma is even more rarely reported and its diagnostic criteria together with its clinical courses is not cleared defined. CASE PRESENTATION: We described two patients with breast leiomyomas. One has unilateral benign breast leiomyoma, the other one has bilateral breast leiomyomas. For the bilateral case, the left-side tumor was diagnosed as benign leiomyoma while the right-side tumor was diagnosed as atypical leiomyoma. The morphological features that lead to the diagnosis of atypical leiomyoma are its invasive growth pattern, mild nuclear atypia, and mitotic figures up to 3mitoses/10HPF. CONCLUSIONS: Atypical breast leiomyoma appears to behave like benign leiomyoma without recurrence in our study with nine-year follow-up. Due to the limited experience, cases presented as atypical intraparenchymal breast leiomyoma should be closely followed.


Assuntos
Neoplasias da Mama , Leiomioma , Neoplasias Uterinas , Neoplasias da Mama/diagnóstico , Neoplasias da Mama/patologia , Proliferação de Células , Feminino , Humanos , Leiomioma/diagnóstico por imagem , Leiomioma/cirurgia , Neoplasias Uterinas/patologia
2.
Org Lett ; 24(18): 3389-3394, 2022 05 13.
Artigo em Inglês | MEDLINE | ID: mdl-35486481

RESUMO

Reported herein is an in situ-generated hypervalent iodine-incorporating fluoroarylation of benzylidenecyclopropanes using commercially available HF·Py and aryl iodides as fluorine and aryl sources, respectively. The reaction proceeds via regioselective 1,2-fluoroiodination of a double bond followed by an iodonio-[3,3]-rearrangement of the formed cyclopropyl-I(III) species. The protocol offers facile access to valuable monofluorinated 1,1-bis-benzyl-alkenes with mild reaction conditions and moderate to good yields. The synthetic utility of the products was demonstrated by further transformations. Preliminary mechanistic studies were conducted.


Assuntos
Iodetos , Iodo , Alcenos/química , Iodo/química , Oxirredução , Estresse Oxidativo
3.
J Clin Med ; 11(6)2022 Mar 14.
Artigo em Inglês | MEDLINE | ID: mdl-35329934

RESUMO

Apocrine carcinoma is a rare subtype of invasive ductal breast cancer that shows apocrine differentiation and largely triple-negative immunohistology. Triple-negative breast cancers are known to have more aggressive clinical courses. However, unlike most other subtypes, it is reported that triple-negative apocrine carcinoma (TNAC) has a better prognosis. Due to the scarcity of reported studies, our knowledge regarding its clinical behavior, prognosis and response to therapy is very limited. In this study, we retrospectively retrieved 41 triple-negative apocrine carcinoma cases from our breast cancer database, with an average follow-up of 32.8 months. It was found that TNAC had a poorer response to neoadjuvant therapy but a better prognosis than other nonapocrine types of triple-negative breast cancer. Meanwhile, TNAC has a low proliferative nature, as indicated by its low Ki-67 index. An updated analysis of the Surveillance, Epidemiology, and End Results database showed that chemotherapy did not improve breast-cancer-specific survival in TNAC patients. Our results suggest that TNAC is a special subtype of triple-negative breast cancer with a better short-term prognosis despite poor response to neoadjuvant chemotherapy.

4.
Technol Cancer Res Treat ; 20: 15330338211027900, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34159849

RESUMO

Triple-negative breast cancer is a heterogeneous disease with different molecular and histological subtypes. The Androgen receptor is expressed in a portion of triple-negative breast cancer cases and the activation of the androgen receptor pathway is thought to be a molecular subtyping signature as well as a therapeutic target for triple-negative breast cancer. Thus, identification of the androgen receptor pathway status is important for both molecular characterization andclinical management. In this study, we investigate the expression of the androgen receptor pathway in metaplastic breast cancer and luminal androgen receptor subtypes of triple-negative breast cancer and found that the androgen receptor pathway was downregulated in metaplastic breast cancer compared to luminal androgen receptor subtype. Using random forest, we found that the two subtypes of breast cancer can be molecularly classified with the gene expression of the androgen receptor pathway.


Assuntos
Expressão Gênica , Receptores Androgênicos/genética , Neoplasias de Mama Triplo Negativas/classificação , Neoplasias de Mama Triplo Negativas/genética , Descarboxilases de Aminoácido-L-Aromático/genética , Subunidade alfa 1 de Fator de Ligação ao Core/genética , Regulação para Baixo , Perfilação da Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Fator 3-alfa Nuclear de Hepatócito/genética , Humanos , Aprendizado de Máquina , Pessoa de Meia-Idade , Proteínas Proto-Oncogênicas c-ets/genética , Receptores Androgênicos/metabolismo , Receptores de Estrogênio/genética , Receptores Acoplados a Proteínas G/genética , Neoplasias de Mama Triplo Negativas/metabolismo
6.
BMC Ophthalmol ; 21(1): 160, 2021 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-33789617

RESUMO

BACKGROUND: Panretinal photocoagulation treatment (PRP) have been known as a standard treatment for proliferative diabetic retinopathy (PDR) or severe nonproliferative diabetic retinopathy (sNPDR). However, there is no consensus on when PRP should be administrated if anti-VEGF treatment is needed for the concurrent diabetic macular edema (DME). This study is to evaluate the difference between two groups of PRP prior to, or after intravitreal conbercept (IVC) for patients with PDR or sNPDR combined with DME. METHODS: This was a retrospective study. Fifty-eight eyes with DME secondary to PDR or sNPDR were divided into two groups; the PRP after (PRP-after group), or prior to (PRP-prior group), IVC. Changes in number of IVC injections, best corrected visual acuity (BCVA), and central subfield macular thickness (CSMT) were compared after 4 weeks, 12 weeks, 1 year, and 2 years from the first IVC injection. RESULTS: The mean number of injections in PRP-after group was 4.8 (1 year) and 6.4 (2 year), lower than 6.4 (1 year) and 8.5 (2 year) in PRP-prior group (both p = 0.002). There was no significant difference in change in BCVA and CSMT between two groups after each follow-up. CONCLUSION: PRP after IVC requires less injections but also yields similar visual and anatomic outcome comparing with PRP prior to IVC in patients with diabetic retinopathy combined with DME.


Assuntos
Diabetes Mellitus , Retinopatia Diabética , Edema Macular , Inibidores da Angiogênese/uso terapêutico , Retinopatia Diabética/complicações , Retinopatia Diabética/tratamento farmacológico , Humanos , Injeções Intravítreas , Fotocoagulação a Laser , Edema Macular/tratamento farmacológico , Edema Macular/cirurgia , Ranibizumab/uso terapêutico , Proteínas Recombinantes de Fusão , Estudos Retrospectivos , Tomografia de Coerência Óptica , Acuidade Visual
7.
Eye Contact Lens ; 44(5): 335-338, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29944504

RESUMO

PURPOSE: To investigate the changes in the quality of life and behaviors in children before and after wearing orthokeratology lenses and to analyze the potential impact of orthokeratology lenses on children's quality of life, behaviors, and the progression of myopia. METHODS: A total of 100 children receiving orthokeratology lenses in the People's Hospital of Hebei Province and the Nanjing First Hospital from January 2016 to February 2017 were enrolled in this study. A questionnaire survey was conducted for the orthokeratology lenses wearers before and 3 months after wearing the orthokeratology lenses, and analysis was performed for the 69 valid questionnaires. RESULTS: The scores of symptom module, entertainment module, and study and life module marked by the children differed significantly 3 months after wearing the orthokeratology lenses. Among 20 entries, the life quality scores of nine surveys before and after wearing lenses were statistically significant (P<0.05). The main reason why the children chose orthokeratology lenses was more convenience in athletic activities (43.5%). The majority of children (75.4%) were willing to accept orthokeratology lenses to correct vision and to alleviate myopia progression. CONCLUSION: Orthokeratology lenses have a good effect on children's quality of life, behaviors, and psychology. The children who wore lenses were more self-confident, more willing to try new things, and more active in participating in sports and entertainment, resulting in an increasing trend of the total time spent on outdoor activities.


Assuntos
Lentes de Contato , Miopia/psicologia , Miopia/terapia , Procedimentos Ortoceratológicos , Qualidade de Vida , Adolescente , Criança , Comportamento Infantil/psicologia , Feminino , Humanos , Atividades de Lazer , Masculino , Procedimentos Ortoceratológicos/métodos , Aceitação pelo Paciente de Cuidados de Saúde , Autoeficácia , Comportamento Social , Acuidade Visual
8.
Med Hypotheses ; 113: 74-76, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29523300

RESUMO

The rigid gas permeable contact lens (RGPCL) is an ideal choice to improve the corrective vision of patients with a high degree of refractive error, keratoconus and corneal transplantation. However, RGPCL fitting is not an easy work for those patients with extremely irregular corneal surface. Technicians or doctors often need to try many times to determine the relatively satisfied lens customization parameters. This repeated try-on process not only increases discomfort of patients, but also will increase the risks of corneal epithelial shedding or corneal infection. In order to conduct RGP fitting in a faster and safer manner, a new method of simulating RGPCL fitting in 3D printing technology was assumed. The preliminary experimental results indicated that this method could effectively reduce the number of try-on and increase patient satisfaction, while decrease the risk of epithelial shedding or infection.


Assuntos
Lentes de Contato , Córnea/fisiologia , Impressão Tridimensional , Ajuste de Prótese/métodos , Simulação por Computador , Desenho de Equipamento , Humanos , Ceratocone , Erros de Refração , Acuidade Visual
9.
Biomed Pharmacother ; 95: 1704-1709, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28958132

RESUMO

Remodelling of the extracellular matrix and accumulation of fibronectin and collagen type I play critical roles in scar formation following glaucoma filtration surgery. The transforming growth factor ß1 (TGF-ß1) signal transduction pathway is involved in this process in human Tenon's fibroblasts (HTFs). The type 2 cannabinoid receptor (CB2R) is an important member of the cannabinoid receptor family of G protein-coupled receptors. In this study, we investigated the effects of the CB2R agonists HU308 and JWH133 on the deposition of newly formed extracellular matrix (ECM) and the contractility of HTFs. CB2R was expressed in HTFs. Notably, the CB2R agonists HU308 and JWH133 ameliorated TGF-ß1-induced generation of fibronectin, types I and III collagen, and the expression of matrix metalloproteinase 1 (MMP-1) and MMP-3. In addition, the CB2R agonists HU308 and JWH133 ameliorated TGF-ß1-induced matrix contraction and remodelling in a dose- and time-dependent manner, respectively. HU308 and JWH133 also suppressed the TGF-ß1-induced activation of mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinase 1/2 (ERK1/2), p38, and c-Jun N-terminal kinase (JNK). Based on our results, agonistic activation of CB2R exerts a protective effect on scarring during the healing of wounds from glaucoma filtration surgery.


Assuntos
Agonistas de Receptores de Canabinoides/farmacologia , Matriz Extracelular/efeitos dos fármacos , Fibroblastos/efeitos dos fármacos , Receptor CB2 de Canabinoide/agonistas , Agonistas de Receptores de Canabinoides/administração & dosagem , Canabinoides/administração & dosagem , Canabinoides/farmacologia , Células Cultivadas , Colágeno Tipo I/metabolismo , Colágeno Tipo III/metabolismo , Relação Dose-Resposta a Droga , Matriz Extracelular/metabolismo , Fibroblastos/metabolismo , Fibronectinas/metabolismo , Humanos , Metaloproteinase 1 da Matriz/metabolismo , Metaloproteinase 3 da Matriz/metabolismo , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Receptor CB2 de Canabinoide/metabolismo , Cápsula de Tenon/metabolismo , Fatores de Tempo , Fator de Crescimento Transformador beta1/metabolismo , Cicatrização/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA